# Biotechnology startup Tahoe Therapeutics raises USD 30 million to build living-cell AI models

On 2025/8/11, Forbes reported that biotechnology company Tahoe Therapeutics had raised USD 30 million at a USD 120 million valuation, bringing total funding to USD 42 million, with investment from Amplify Partners. It uses living-cell AI models to find new cancer treatments.



Canonical: https://uniquebase.ai/news/b8d8c2ad-e192-4fd6-aaf3-7cbf791bcbbc
Stable identifier: b8d8c2ad-e192-4fd6-aaf3-7cbf791bcbbc
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-16T00:00:28.831Z

## Connected profiles

- [AIX Ventures](/institutions/aix-ventures)
- [Amplify Partners](/institutions/amplify-partners)
- [Civilization Ventures](/institutions/civilization-ventures)
- [Conviction Partners](/institutions/conviction-partners)
- [Databricks Ventures](/institutions/databricks-ventures)
- [General Catalyst](/institutions/general-catalyst)
- [Mubadala Investment Company](/institutions/mubadala-investment-company)
- [Overlap Holdings](/institutions/overlap-holdings)
- [Tahoe Therapeutics](/companies/tahoe-therapeutics)
- [WVC](/institutions/wvc)

## Sources

- https://www.forbes.com/sites/alexknapp/2025/08/11/biotech-startup-tahoe-therapeutics-raised-30-million-to-build-ai-models-of-living-cells/